Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Worms

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Journal De Pharmacologie|April 1, 1986
[Pharmacologic profile of an original psychotropic drug. Minaprine: comparison with six reference antidepressives]P Worms, J P Kan, A Perio, et al.
Psychopharmacology|January 1, 1989
Specific modulation of social memory in rats by cholinomimetic and nootropic drugs, by benzodiazepine inverse agonists, but not by psychostimulantsA Perio, J P Terranova, P Worms, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 1, 1989
Cholinomimetic activities of minaprineP Worms, J P Kan, R Steinberg, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1982
gamma-Aminobutyric acid (GABA) receptor stimulation. I. Neuropharmacological profiles of progabide (SL 76002) and SL 75102, with emphasis on their anticonvulsant spectraP Worms, H Depoortere, A Durand, et al.
Advances in Biochemical Psychopharmacology|January 1, 1981
The role of GABA mediated neurotransmission in convulsive statesK G Lloyd, C Munari, P Worms, et al.
European Journal of Pharmacology|September 21, 1990
Pharmacological activity of cholecystokinin analogues modified in the Met28-Gly29 regionC Mendre, M Rodriguez, M F Lignon, et al.
The Journal of Biological Chemistry|August 5, 1988
A pseudopeptide that is a potent cholecystokinin agonist in the peripheral system is able to inhibit the dopamine-like effects of cholecystokinin in the striatumC Mendre, M Rodriquez, C Gueudet, et al.
Pharmacology, Biochemistry, and Behavior|June 1, 1983
The potential use of GABA agonists in psychiatric disorders: evidence from studies with progabide in animal models and clinical trialsK G Lloyd, P L Morselli, H Depoortere, et al.
Journal of Medicinal Chemistry|June 1, 1980
New anticonvulsants: Schiff bases of gamma-aminobutyric acid and gamma-aminobutyramideJ P Kaplan, B M Raizon, M Desarmenien, et al.
Journal of Medicinal Chemistry|March 1, 1989
3-aminopyridazine derivatives with atypical antidepressant, serotonergic, and dopaminergic activitiesC G Wermuth, G Schlewer, J J Bourguignon, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Journal De Pharmacologie|April 1, 1986
[Pharmacologic profile of an original psychotropic drug. Minaprine: comparison with six reference antidepressives]P Worms, J P Kan, A Perio, et al.
Psychopharmacology|January 1, 1989
Specific modulation of social memory in rats by cholinomimetic and nootropic drugs, by benzodiazepine inverse agonists, but not by psychostimulantsA Perio, J P Terranova, P Worms, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 1, 1989
Cholinomimetic activities of minaprineP Worms, J P Kan, R Steinberg, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1982
gamma-Aminobutyric acid (GABA) receptor stimulation. I. Neuropharmacological profiles of progabide (SL 76002) and SL 75102, with emphasis on their anticonvulsant spectraP Worms, H Depoortere, A Durand, et al.
Advances in Biochemical Psychopharmacology|January 1, 1981
The role of GABA mediated neurotransmission in convulsive statesK G Lloyd, C Munari, P Worms, et al.
European Journal of Pharmacology|September 21, 1990
Pharmacological activity of cholecystokinin analogues modified in the Met28-Gly29 regionC Mendre, M Rodriguez, M F Lignon, et al.
The Journal of Biological Chemistry|August 5, 1988
A pseudopeptide that is a potent cholecystokinin agonist in the peripheral system is able to inhibit the dopamine-like effects of cholecystokinin in the striatumC Mendre, M Rodriquez, C Gueudet, et al.
Pharmacology, Biochemistry, and Behavior|June 1, 1983
The potential use of GABA agonists in psychiatric disorders: evidence from studies with progabide in animal models and clinical trialsK G Lloyd, P L Morselli, H Depoortere, et al.
Journal of Medicinal Chemistry|June 1, 1980
New anticonvulsants: Schiff bases of gamma-aminobutyric acid and gamma-aminobutyramideJ P Kaplan, B M Raizon, M Desarmenien, et al.
Journal of Medicinal Chemistry|March 1, 1989
3-aminopyridazine derivatives with atypical antidepressant, serotonergic, and dopaminergic activitiesC G Wermuth, G Schlewer, J J Bourguignon, et al.
Pageof 6